论文部分内容阅读
新一期国际权威期刊《肝病学杂志》发布了第二军医大学东方肝胆外科医院周伟平教授等人的科研成果。他们为期5年的随机对照临床研究表明:对于超米兰标准的中期多发性肝癌患者,应用肝切除术治疗能提高生存率,效果显著好于介入治疗。这颠覆了欧洲肝脏研究学会推荐的巴塞罗那指南,即中期肝癌患者最佳的治疗方案是介入——而这一共识自1999年以来基本未变。米兰标准界定的是肿瘤状况,具体是指单个肿瘤直径不超过5cm或较多发肿瘤少于3个且最大直径不超过3cm,没有大血管侵犯现象,也没
The new issue of the international authoritative journal “Journal of Hepatology” released the Second Military Medical University Eastern Hepatobiliary Surgery Hospital, Professor Zhou Weiping and other scientific research. Their five-year, randomized, controlled clinical study showed that hepatectomy can improve survival rates in patients with meta-multiple-medium-term multiple hepatocellular carcinoma, which is significantly better than interventional therapy. This subverts the Barcelona guidelines recommended by the European Association for the Study of the Liver that the best treatment option for patients with HCC is intervention - and that consensus has remained essentially unchanged since 1999. The Milan criteria define the condition of a tumor, which means that a single tumor has a diameter of no more than 5 cm or more than 3 tumors with a maximum diameter of no more than 3 cm, no major blood vessel invasion, and no